 |
Viatris
VTRS
|
$ 12.66
|
15.3 B
|
$ 172 M
|
-4.4
|
1.1
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 8.74
|
5.4 B
|
$ -105 M
|
-3.8
|
6.6
|
$ -2.3
|
 |
 |
Bausch Health Companies
BHC
|
$ 6.75
|
2.46 B
|
$ 3.23 B
|
-6.1
|
0.3
|
$ -1.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 15.06
|
2.07 B
|
$ 579 M
|
-71.7
|
0.5
|
$ -0.2
|
 |
 |
Avadel Pharmaceuticals plc
AVDL
|
$ 21.51
|
2.05 B
|
$ -71.4 M
|
-179.2
|
8.2
|
$ -0.1
|
 |
 |
Harrow Health
HROW
|
$ 47.49
|
1.55 B
|
$ 17.6 M
|
-105.5
|
6.7
|
$ -0.4
|
 |
 |
Cronos Group
CRON
|
$ 2.56
|
1.35 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Pacira BioSciences
PCRX
|
$ 19.43
|
899 M
|
$ -75.6 M
|
-6.5
|
1.3
|
$ -3.0
|
 |
 |
Assertio Holdings
ASRT
|
$ 12.04
|
855 M
|
$ -3.27 M
|
-54.7
|
6.4
|
$ -0.2
|
 |
 |
Emergent BioSolutions
EBS
|
$ 11.08
|
567 M
|
$ -238 M
|
-1.5
|
0.5
|
$ -7.5
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 3.64
|
479 M
|
$ 2.42 M
|
-52.0
|
1.1
|
$ -0.1
|
 |
 |
Veru
VERU
|
$ 2.53
|
341 M
|
$ -36.3 M
|
-1.9
|
25.1
|
$ -1.4
|
 |
 |
Evolus
EOLS
|
$ 5.05
|
313 M
|
$ -48.4 M
|
-4.6
|
1.2
|
$ -1.1
|
 |
 |
Solid Biosciences
SLDB
|
$ 5.59
|
228 M
|
$ -115 M
|
-2.4
|
11.6
|
$ -2.3
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 3.93
|
118 M
|
$ -165 M
|
-2.1
|
-110.4
|
$ -1.9
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 4.74
|
66.6 M
|
$ 1.01 M
|
-22.6
|
1.7
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.65
|
31.1 M
|
$ -72.9 M
|
-1.4
|
11.9
|
$ -0.5
|
 |
 |
Rockwell Medical
RMTI
|
$ 1.22
|
28.5 M
|
$ 1.12 M
|
-30.5
|
0.3
|
$ -0.0
|
 |
 |
TherapeuticsMD
TXMD
|
$ 2.55
|
26.6 M
|
$ -3.18 M
|
-51.0
|
10.0
|
$ -0.0
|
 |
 |
China Pharma Holdings
CPHI
|
$ 1.25
|
21.8 M
|
$ -1.98 M
|
-1.0
|
5.4
|
$ -1.2
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 3.33
|
4.13 M
|
$ -5.22 M
|
-1.4
|
0.2
|
$ -2.3
|
 |
 |
cbdMD
YCBD
|
$ 0.83
|
3.58 M
|
$ -1.2 M
|
-0.1
|
0.2
|
$ -11.3
|
 |